We specialise in integrating genomics, machine learning, and AI to enhance the early and accurate diagnosis of cancer, predict treatment responses, and monitor patient outcomes.
Our flagship technology, Melaseq™, is clinically and technically validated to provide doctors with a reliable tool for detecting and diagnosing cutaneous melanoma with genomic precision.
You must be logged in to post a comment.